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Toward the Isolation and Culture  
of Melanocyte Stem Cells
Sung-Jan Lin1–4 and Cheng-Ming Chuong1,4
A new level of understanding of pigment cell biology and pathology will require 
the ability to culture and manipulate melanocyte stem cells (MCSCs) in vitro. In 
this issue, Nishikawa-Torikai et al. report progress toward this end. MCSCs iso-
lated from mouse hair follicles can be expanded in vitro in a feeder-layer culture 
system. Application to human systems can be expected.
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recent progress in mcScs is based  
on in vivo studies using genetically 
engineered mice
Major progress in skin MCSC research 
has been made over the past decade 
through the use of genetically engi-
neered mice. Previously, melanocyte 
research was focused more on mela-
nocyte development and the behav-
ior of unsorted adult melanocytes. 
Nishikawa’s group (Nishimura et al., 
2002) first identified MCSCs in hair 
follicles (HFs) using genetically engi-
neered mice with a LacZ reporter 
driven by the promoter of the early 
melanocyte-development gene, Dct 
(or TRP-2). With these genetic tools 
and lineage-tracing strategies, they 
were able to verify MCSCs function-
ally, mapping the MCSC niche to 
the lower permanent portion of HFs 
(including the bulge). Later, also with 
the use of genetically engineered mice, 
researchers started to shed more light 
on the cell dynamics and regulation of 
MCSCs: quiescence, activation, differ-
entiation, self-maintenance, response 
to injury, and interactions with neigh-
bors (Nishimura et al., 2005; Inomata 
et al., 2009; Nishimura, 2011; Rabbani 
et al., 2011).
MCSCs are activated, proliferate, 
and give rise to amplifying progeny 
only in early anagen (Nishimura et al., 
2002) (Figure 1a). It is suggested that 
this activation is dependent on c-Kit and 
Wnt/β-catenin signaling (Botchkareva 
et al., 2001; Rabbani et al., 2011). The 
amplifying progeny colonize in the 
hair bulb, where they differentiate and 
transfer melanosomes to keratinocytes. 
The niche environment plays an active 
role in the activation and maintenance 
of MCSCs. For example, secreted Wnt 
ligands and transforming growth factor-β 
from bulge keratinocytes are vital to the 
activation and quiescent maintenance 
of MCSCs, respectively (Nishimura et 
al., 2010; Rabbani et al., 2011). Failure 
to maintain MCSCs in their niche may 
cause premature MCSC depletion, lead-
ing to early hair pigment loss (Nishimura 
et al., 2005). Together, these studies 
have added to our understanding of the 
identity, niche location, cell dynamics, 
and regulation of HF MCSCs (see also 
the recent review by Nishimura (2011)).
However, only a few studies have 
examined MCSC behavior in other 
mammals, including humans, because 
of the lack of a similar genetic method-
ology. As shown in keratinocyte 
research, the isolation and in vitro cul-
ture system for keratinocyte stem cells 
have helped to provide more insight into 
the behavior and regulation of keratino-
cyte stem cells. A method allowing the 
isolation and characterization of MCSCs 
will be important for the field of pigment 
cell biology and pathology.
Successful isolation of mouse mcScs
In this issue, Nishikawa’s group tries to 
bridge this gap in melanocyte research. 
In a 2008 publication, the same group 
reported an in vitro culture system for 
embryonic melanoblasts using a feeder 
layer of XB2 keratinocyte and growth fac-
tors (e.g., stem cell factor, basic fibroblast 
growth factor) (Yonetani et al., 2008). 
On the basis of this strategy, they now 
present in this issue a method to isolate 
and culture MCSCs from adult murine 
HFs (Figure 1b). Starting from a trans-
genic mouse (Dcttm1(Cre)Bee/CAG-CAT-GFP 
mouse strain) that specifically expresses 
green fluor escent protein in melanocytes 
for cell sorting, they found that only 
melanocytes from the lower permanent 
portion of anagen follicles are able to 
proliferate in vitro; melanocytes isolated 
from hair bulbs are not. When surface 
marker and side-scatter (SSC) profiles 
were characterized further, the investi-
gators discovered that immature mela-
nocytes in the lower permanent portion 
of HFs are c-KitlowSSClow whereas mature 
melanocytes in hair bulbs are c-KithighSS-
Chigh. Functionally, only the c-KitlowSSClow 
melanocytes had clonogenic activ-
ity. The c-KitlowSSClow cells were able to 
proliferate as well as to differentiate in 
response to exogenous growth factors in 
vitro. Nishikawa-Torikai and co-workers 
then tested whether this method could 
be used to isolate and culture MCSCs 
from wild-type mice. They demonstrated 
that about 0.1% of the cells from wild-
type mouse HFs are c-KitlowSSClow. These 
cells were able to proliferate and also to 
differentiate in vitro in response to dif-
ferentiation signals. Moreover, in a hair-
regeneration assay, the c-KitlowSSClow 
cells, either cultured or freshly isolated, 
were able to populate new HFs, includ-
ing the MCSC niche, and to generate 
pigment cells in future hair cycles.
commentary
2342 Journal of Investigative Dermatology (2011), Volume 131 
This culture system might need 
further improvement, as the authors 
acknowledge, because it allows MCSC 
expansion for up to only three pas-
sages, beyond which most cells go 
on to differentiate. However, it is the 
first step toward culturing MCSCs in 
vitro. The fact that not all c-KitlowSSClow 
melanocytes are clonogenic in vitro 
is significant in that it suggests that all 
c-KitlowSSClow melanocytes or MCSCs 
might not be equal in vivo. Some may 
have already become committed to dif-
ferentiation and hence lose their prolif-
erative potential. Further study will be 
required to differentiate these cells.
Implications for human mcSc biology 
and diseases
If we can isolate human MCSCs, it 
will enhance our understanding of the 
pathogenesis of pigment cell–related 
diseases. Several examples are high-
lighted here. Amelanotic melanocytes 
have been shown to be present in the 
basal layer of the outer root sheath of 
normal human HFs (Staricco, 1963). 
These cells very likely correspond to 
the recently reported putative MITFlow 
small unpigmented MCSCs preferen-
tially located at the basal outer root 
sheath around the bulge area of young 
human HFs (Nishimura et al., 2005). 
Whether the bulge MITFlow small 
amelanotic melanocytes are bona fide 
human MCSCs remains to be clari-
fied. These putative MITFlow MCSCs 
have been shown to be associated with 
human diseases and treatment effects 
(Nishimura et al., 2005; Nishimura, 
2011).
In senile gray hairs, the number of 
these putative MITFlow MCSCs is greatly 
decreased or absent in the bulge area 
(Nishimura et al., 2005), but MITFhigh 
melanocytes are still preserved in the 
follicular infundibulum and interfollicu-
lar epidermis. Transplanted interfollicu-
lar melanocytes are able to repopulate 
apigmented HFs of patients with vitiligo 
and piebaldism (Horikawa et al., 1999; 
Hartmann et al., 2008). Why are infun-
dibular and epidermal melanocytes 
unable to migrate and repopulate the 
empty niche during human hair gray-
ing? Whether this progressive loss of 
MCSCs in humans is an intrinsic defect 
of MCSCs or is caused by an alteration 
in the surrounding environment remains 
to be determined. Understanding the 
pathogenesis may help to develop meth-
ods for preventing the loss of—or even 
for restoring—MCSCs in hair graying.
In vitiligo under photochemotherapy, 
early work has suggested that amela-
notic melanocytes in HFs proliferate, 
differentiate, and migrate out to inter-
follicular epidermis, leading to “fol-
licular repigmentation” (Staricco, 1963; 
Cui et al., 1991). However, whether 
this effect of phototherapy is through 
direct activation of HF MCSCs requires 
further investigation. It was observed 
that the follicular repigmentation under 
phototherapy seems to be independent 
of the hair cycle (Cui et al., 1991). This 
contrasts with the current view in physi-
ological HF pigmentation obtained from 
genetically engineered mice, that is, that 
MCSCs are activated only in early ana-
gen (Nishimura et al., 2002; Rabbani et 
al., 2011). How do we explain this treat-
ment effect in humans? As suggested by 
Nishikawa-Torikai et al. (2011), MCSCs 
themselves might not be equal. Hence, 
it is possible that some apigmented 
melanocytes in the human bulge might 
already be committed and are able to 
proliferate and differentiate in response 
to such phototherapy, even in telogen. 
Figure 1. melanocyte stem cell (mcSc) behavior, its isolation and culture, and the clinical 
application. (a) Murine MCSCs are located in the lower permanent portion of hair follicles (HFs) 
and are activated in early anagen, giving rise to the amplifying progeny that proliferate and 
differentiate into functional melanocytes in the hair bulb. (b) Using fluorescence-activated cell 
sorter (FACS), clonogenic c-Kitlowside-scatter (SSC)low MCSCs are isolated from wild-type mouse 
HFs and can be expanded in vitro in an XB2 keratinocyte feeder-layer culture system. (c) The in 
vitro expanded MCSCs allow in vitro biomolecular analysis and drug screening and have the 
potential to be applied to clinical transplantation for the treatment of pigment cell loss. bFGF, 
basic fibroblast growth factor; SCF, stem cell factor.
Clinical Implications
•  Murine hair follicle melanocyte stem cells are isolated via fluorescence-
activated cell sorter by a c-Kitlow side-scatterlow profile. Isolated 
melanocyte stem cells can be cultured and expanded, enabling further 
in vitro analysis.
•  The approach can be further developed to investigate melanocyte stem 
cells under normal and diseased conditions in humans, such as vitiligo 
and hair graying.
•  Follicular repigmentation of vitiliginous skin by phototherapy is 
suggested to work through activating and mobilizing immature 
melanocytes or melanocyte stem cells located in the bulge region. This 
line of work may help clarify whether this treatment works directly on 
melanocyte stem cells or indirectly, by changing the environment.
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Other “true” MCSCs may remain 
quiescent, and thus the MCSC reservoir 
is preserved during phototherapy.
If bona fide MCSCs are activated by 
phototherapy, what is the underlying 
mechanism responsible for this effect 
of uncoupling MCSC activation from 
hair follicle stem cell activation? Does it 
work directly through activating MCSCs 
or indirectly through modifying the 
environment? How do we activate and 
enhance this effect in patients who do 
not respond to phototherapy? To answer 
these questions, we need new method-
ologies (Figure 1c). The method to isolate 
and culture murine MCSCs developed 
by Nishikawa’s group brings us closer 
to a position in which we are capable of 
isolating and culturing human MCSCs 
for treatment, pharmaceutical testing, 
and pathophysiological investigation.
In summary, the breakthrough in cul-
turing technology for murine MCSCs will 
allow further bench biomolecular pertur-
bation and characterization. The in vitro 
studies will be complementary to results 
obtained in vivo. Furthermore, the con-
cept and approach Nishikawa-Torikai 
et al. (2011) propose can be developed 
and applied to isolating human MCSCs. 
Their findings are expected to facilitate 
research in human melanocytes as well 
as clinical applications of MCSCs.
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Axl of evil?
Andrew E. Aplin1,2
Receptor tyrosine kinases (RTKs) play key roles in the initiation and progres-
sion of human skin cancers, yet the importance of some RTKs remains poorly 
understood. In this issue, Sensi et al. provide new insights into the expres-
sion and function of the RTK, Axl, in melanoma. The investigators show that 
Axl is frequently expressed in melanoma cell lines, particularly mutant NRAS-
harboring lines, and that Axl activation by its ligand, Gas6, probably occurs via 
both autocrine and paracrine mechanisms. Gene signatures from Axl-expressing 
cell lines are similar to published signatures from poorly differentiated tumors 
displaying high metastatic potential. functionally, Axl was required for the inva-
sive and migratory properties of Axl-expressing melanoma cell lines. These data 
emphasize that targeting the Gas6–Axl signaling axis should be investigated as a 
strategy to inhibit prometastatic properties in poorly differentiated melanomas.
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Axl was originally identified as a 
transforming gene in chronic myelog-
enous leukemia (Liu et al., 1988). Its 
name was derived from the Greek 
word anexelekto, meaning “uncon-
trolled” (O’Bryan et al., 1991), and 
it was characterized as a receptor 
tyrosine kinase (RTK) in the TAM 
(Tyro-3, Axl, Mer) subfamily. Aberrant 
expression and activation of RTKs are 
implicated in melanoma progression 
(Tworkoski et al., 2011), as well as in 
melanoma resistance to targeted ther-
apies (Villanueva et al., 2010). Axl has 
been found to be upregulated in many 
cancer types; however, the impor-
tance of this RTK in melanoma has 
not been clearly elucidated. In their 
article in this issue, Sensi et al. seek to 
fill this gap.
